z.yildiz
TL2 Moderator · Angers
Contributes reviews on supplier material. Based in Angers.
Joined 1 September 2025 · last posted 8h
76 posts, newest first. Showing up to 150.
-
Revisiting: Body image changing more slowly than the body Replied, post #10 · Wellbeing › Mental health · 28 Jul 2026 · 11 likes Worth separating two things that post #6 runs together. Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #26 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 16 likes Picking up post #23: that is the part I would want checked first. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH…
-
Revisiting: The best-written scientific paper you have read Replied, post #102 · Lounge › Off topic · 19 Jul 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Revisiting: The best-written scientific paper you have read Replied, post #89 · Lounge › Off topic · 13 Jul 2026 · 16 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Reading a home test result without over-claiming Replied, post #114 · Analytics › Home & field testing · 11 Jul 2026 · 5 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Asking a follow-up: new topic or new reply? Replied, post #44 · Start Here › How to Ask · 9 Jul 2026 · 7 likes Coming back to post #42, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
What I would want from a home test that does not exist yet Replied, post #29 · Analytics › Home & field testing · 6 Jul 2026 · 10 likes Coming back to post #27, because the follow-up matters more than the original answer. Sample handling matters: if a sample is contaminated or degraded before testing,…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #4 · Clinical › Prescriber conversations · 3 Jul 2026 · 0 likes Picking up post #3: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Follow-up: UK access routes, dated and sourced Replied, post #8 · Regional › UK & Ireland · 30 Jun 2026 · 13 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #41 · Access › International · 27 Jun 2026 · 1 like Coming back to post #39, because the follow-up matters more than the original answer. Insurance and coverage: coverage decisions are national. A compound approved in…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #58 · Analytics › Home & field testing · 26 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #12 · Compounds › Semaglutide · 19 Jun 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #26 · Access › Insurance & coverage · 18 Jun 2026 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Reading a home test result without over-claiming Replied, post #81 · Analytics › Home & field testing · 16 Jun 2026 · 0 likes Worth separating two things that post #77 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #89 · Practice › Side effects · 4 Jun 2026 · 0 likes On post #85 — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 3 Jun 2026 · 7 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #102 · Devices › Syringes & needles · 9 May 2026 · 2 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #14 · Clinical › Prescriber conversations · 25 Apr 2026 · 4 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #106 · Pharmacology › Pharmacokinetics · 15 Apr 2026 · 15 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
List price versus negotiated price versus what you pay Replied, post #6 · Access › Pricing · 7 Apr 2026 · 2 likes I read post #4 twice before replying, because I had assumed the opposite. International pricing: the same compound costs very different amounts in different countries…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #8 · Compounds › Retatrutide · 2 Apr 2026 · 2 likes post #7 answers the question as asked. The question underneath it is different. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
-
Follow-up: Search filters: what is missing Replied, post #65 · Meta › Site feedback · 30 Mar 2026 · 16 likes post #64 is right about the mechanism and I think understates the practical bit. Feature requests: if the site would work better with a feature it does not have (better…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #77 · Practice › Reconstitution · 28 Mar 2026 · 0 likes This follows post #74 rather than contradicting it. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
How to ask about something you suspect is a bad idea Replied, post #66 · Start Here › How to Ask · 17 Mar 2026 · 25 likes Picking up post #63: that is the part I would want checked first. Five questions in one post gets you one answer: the easiest one, usually not the one you needed most.…
-
Forced degradation studies: designing one that is informative Replied, post #19 · Analytics › Method validation · 13 Mar 2026 · 1 like I read post #17 twice before replying, because I had assumed the opposite. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #14 · Compounds › Oral incretins · 2 Mar 2026 · 0 likes Picking up post #11: that is the part I would want checked first. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial.…
-
Managing an unplanned gap in supply Replied, post #43 · Access › Shortages · 26 Feb 2026 · 0 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Moderation log format change Replied, post #28 · Meta › Announcements · 11 Feb 2026 · 0 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Five questions in one post gets you one answer — how to split them Replied, post #8 · Start Here › How to Ask · 6 Feb 2026 · 17 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Trifluoroacetate content and its consequences Replied, post #36 · Analytics › Impurities & related substances · 28 Jan 2026 · 32 likes On post #32 — agreed on the reasoning, with one qualification. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #2 · Analytics › Mass spectrometry · 4 Jan 2026 · 5 likes Resolution: "high resolution" commonly means
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #75 · Compounds › Oral incretins · 4 Dec 2025 · 6 likes Picking up post #72: that is the part I would want checked first. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #69 · Compounds › Oral incretins · 4 Dec 2025 · 6 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
The headache that turns out to be dehydration Replied, post #68 · Nutrition & Training › Hydration & electrolytes · 24 Nov 2025 · 29 likes This follows post #65 rather than contradicting it. Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium,…
-
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #15 · Practice › Side effects · 23 Nov 2025 · 0 likes Worth separating two things that post #11 runs together. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
-
Lurking for two months before posting: was that the right call? Replied, post #52 · Start Here › Welcome · 20 Nov 2025 · 6 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
Substitution between formats during a shortage Replied, post #84 · Access › Shortages · 28 Oct 2025 · 1 like Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Managing an unplanned gap in supply — what changed since Replied, post #98 · Access › Shortages · 26 Oct 2025 · 0 likes This follows post #95 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Follow-up: What a seizure notice actually says Replied, post #20 · Sourcing › Logistics · 25 Oct 2025 · 5 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Washout: how long is long enough, and for what purpose Replied, post #71 · Pharmacology › Pharmacokinetics · 27 Sep 2025 · 1 like Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #24 · Compounds › Tirzepatide · 20 Sep 2025 · 8 likes Coming back to post #22, because the follow-up matters more than the original answer. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #56 · Practice › Storage & stability · 19 Sep 2025 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #62 · Practice › Storage & stability · 18 Sep 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Are there stupid questions here? A staff answer, at length Replied, post #10 · Start Here › Welcome · 24 Jul 2025 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Asking about a compound your prescriber has not heard of Replied, post #91 · Clinical › Prescriber conversations · 11 Jul 2025 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Why plausible mechanism is not evidence of effect Replied, post #19 · Compounds › Repair & healing peptides · 3 Jul 2025 · 2 likes On post #15 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #77 · Nutrition & Training › Protein & intake · 13 Jun 2025 · 0 likes post #76 answers the question as asked. The question underneath it is different. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but…
-
Reading a trial's population section before its results — does this still hold? Replied, post #148 · Evidence › Trials · 26 May 2025 · 19 likes Coming back to post #146, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
-
When to stop reading forums, including this one — the long version Replied, post #18 · Wellbeing › Mental health · 14 May 2025 · 9 likes This follows post #15 rather than contradicting it. Support and community: some people process weight change through community (online or in-person). Others prefer…
-
Reading a trial's population section before its results — does this still hold? Replied, post #96 · Evidence › Trials · 12 May 2025 · 26 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #70 · Compounds › Tirzepatide · 26 Apr 2025 · 3 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Sequence verification for an obscure compound: how it is done Replied, post #18 · Compounds › Other compounds · 23 Apr 2025 · 4 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Retatrutide dose escalation in the published trials Replied, post #149 · Compounds › Retatrutide · 18 Apr 2025 · 0 likes On post #145 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #57 · Evidence › Journal club · 14 Apr 2025 · 0 likes Picking up post #54: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #14 · Clinical › Bloodwork · 2 Apr 2025 · 13 likes Coming back to post #12, because the follow-up matters more than the original answer. Time of day: some biomarkers vary across the day. Cortisol in the morning differs…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #41 · Access › Insurance & coverage · 25 Mar 2025 · 11 likes This follows post #38 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #80 · Compounds › Semaglutide · 27 Feb 2025 · 0 likes This follows post #77 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #16 · Pharmacology › Receptor biology · 27 Feb 2025 · 22 likes Picking up post #13: that is the part I would want checked first. Long-term receptor changes: very little is known about what happens to receptor expression,…
-
Coming back to: Official shortage notices and what they authorise Replied, post #41 · Access › Shortages · 25 Feb 2025 · 30 likes Worth separating two things that post #37 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #27 · Documentation › Doc review · 19 Feb 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Citation checking: if a maintained page cites a paper, the citation should match…
-
Protein density versus volume when you cannot eat much Replied, post #9 · Nutrition & Training › Protein & intake · 23 Jan 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What changed in 2026, by region Replied, post #93 · Access › International · 22 Jan 2025 · 7 likes Worth separating two things that post #89 runs together. Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others…
-
Telehealth prescribing models in the US Replied, post #38 · Regional › North America · 27 Dec 2024 · 9 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #86 · Compounds › Tirzepatide · 23 Dec 2024 · 28 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #2 · Practice › Administration · 17 Dec 2024 · 16 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Converting between mg/mL and units per dose, both directions Replied, post #125 · Practice › Reconstitution · 11 Dec 2024 · 5 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Two sessions a week versus four: what the evidence supports Replied, post #18 · Nutrition & Training › Resistance training · 29 Nov 2024 · 0 likes Picking up post #15: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #32 · Compounds › Semaglutide · 26 Oct 2024 · 4 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Converting between mg/mL and units per dose, both directions Replied, post #47 · Practice › Reconstitution · 11 Oct 2024 · 4 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Progressive overload when the scale is falling — one year on Replied, post #141 · Nutrition & Training › Resistance training · 9 Oct 2024 · 16 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #69 · Clinical › Bloodwork · 30 Sep 2024 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Reference intervals: constructed to contain the central 95% of a reference population, which…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #23 · Analytics › Impurities & related substances · 31 Aug 2024 · 17 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #20 · Evidence › Journal club · 18 Aug 2024 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #35 · Evidence › Journal club · 17 Jul 2024 · 0 likes On post #31 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
How this community labels and discusses unrefereed work Replied, post #74 · Evidence › Preprints · 10 Jul 2024 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Spreadsheets: an appreciation Replied, post #6 · Lounge › Off topic · 5 Jun 2024 · 15 likes I read post #4 twice before replying, because I had assumed the opposite. Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.